InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by HUTT PETER BARTON. Director active across 1 company, notably Concert Pharmaceuticals, INC.. In total, 6 reports have been published. Split: 0 buy · 1 sell. Total volume traded: €22k. Activity tracked since 14 October 2022. The latest transaction was filed on 14 October 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
6 of 6 declarations